Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.43 |
| ▸ | DNM1 | Q05193 | 9/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | F13A1 | P00488 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CA3 | P07451 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | CA6 | P23280 | 1/20 | 0.34 |
| ▸ | CA5A | P35218 | 1/20 | 0.34 |
| ▸ | THPO | P40225 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11733007 | 0.92 | EPHX1 (0.36) | EPHX1TSHRMEN1KMT2ACA12 | |
| SCHEMBL978054 | 0.83 | — | — | |
| SCHEMBL1408879 | 0.80 | EPHX1 (0.55) | EPHX1DNM1TSHRMEN1KMT2A | |
| SCHEMBL8502653 | 0.80 | EPHX1 (0.55) | EPHX1DNM1TSHRMEN1KMT2A | |
| SCHEMBL1408762 | 0.80 | EPHX1 (0.55) | EPHX1DNM1TSHRMEN1KMT2A | |
| SCHEMBL487567 | 0.80 | — | — | |
| SCHEMBL34358 | 0.80 | — | — | |
| SCHEMBL6230952 | 0.80 | EPHX1 (0.55) | EPHX1DNM1TSHRMEN1KMT2A | |
| SCHEMBL1408947 | 0.80 | EPHX1 (0.55) | EPHX1DNM1TSHRMEN1KMT2A | |
| SCHEMBL1408882 | 0.80 | EPHX1 (0.55) | EPHX1DNM1TSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 366 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4748489-A1 | FUNCTIONALIZED MAGNETIC NANOPARTICLES | The Cultivated B. GmbH (DE) | 2026-05-27 | — | — | EP | claimed |
| US-12624143-B2 | Polyamide-functionalized silicon carbide (SiC) nanoparticles-based ceramic membrane for separating an oil and water mixture | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2026-05-12 | — | — | US | claimed |
| EP-3529816-B1 | SOLID ELECTROLYTIC CAPACITOR WITH IMPROVED PERFORMANCE AT HIGH TEMPERATURES AND VOLTAGES | KYOCERA AVX COMPONENTS CORP (US) | 2026-05-06 | — | — | EP | claimed |
| US-20260079095-A1 | SOLID SUPPORTS USEFUL FOR TISSUE ADHERENCE | SINGULAR GENOMICS SYSTEMS INC (US) | 2026-03-19 | — | — | US | claimed |
| EP-4700098-A1 | HIGH-SOLIDS TRIGLYCERIDE OIL BASED WOOD COATING COMPOSITIONS | SPSV B.V. (NL) | 2026-02-25 | — | — | EP | claimed |
| US-20250154325-A1 | VANILLIC ACID-BASED ORGANIC-INORGANIC COMPOUND, CURABLE COMPOSITION, AND PRODUCTION METHOD THEREOF | ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE (KR) | 2025-05-15 | — | — | US | claimed |
| US-20250034623-A1 | MANIPULATING AND DETECTING BIOLOGICAL SAMPLES | FIRST-CITIZENS BANK & TRUST COMPANY | 2025-01-30 | — | — | US | claimed |
| US-20250006933-A1 | FUNCTIONALIZED SILICON NANOPARTICLES, COMPOSITE MATERIALS INCLUDING THEM, AND PREPARATION AND USES THEREOF | ASPEN AEROGELS, INC. (US) | 2025-01-02 | — | — | US | claimed |
| US-12181388-B2 | Device for tissue section immobilization and retention | Singular Genomics Systems, Inc. (US) | 2024-12-31 | — | — | US | claimed |
| US-20240400741-A1 | POLYAMIDE-FUNCTIONALIZED SILICON CARBIDE (SIC) NANOPARTICLES-BASED CERAMIC MEMBRANE FOR SEPARATING AN OIL AND WATER MIXTURE | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-12-05 | — | — | US | claimed |
| WO-2016118110-A1 | METHODS AND COMPOSITIONS FOR STABILIZING FRACTURE FACES DURING HYDRAULIC FRACTURING TREATMENTS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2016-07-28 | — | — | WO | claimed |
| US-20160160114-A1 | Control of Resin Curing | HALLIBURTON ENERGY SERVICES, INC. (US) | 2016-06-09 | — | — | US | claimed |
| US-20160108271-A1 | SILVER NANOPARTICLE INKS COMPRISING AMINOMETHYLSILANES | XEROX CORPORATION | 2016-04-21 | — | — | US | claimed |
| EP-3001819-A1 | A METHOD FOR PRODUCING A CRYSTALLINE FILM OF ZEOLITE AND/OR ZEOLITE LIKE CRYSTALS ON A POROUS SUBSTRATE | Hedlund, Jonas (SE) | 2016-04-06 | — | — | EP | claimed |
| US-20160010241-A1 | METHOD FOR PRODUCING NANOFIBERS CAPABLE OF STORING AND TRANSFERRING NITRIC OXIDE AND NANOFIBERS CAPABLE OF STORING AND TRANSFERRING NITRIC OXIDE PRODUCED THEREBY | I-SENS, INC. (KR) | 2016-01-14 | — | — | US | claimed |
| WO-2015191038-A1 | CONTROL OF RESIN CURING | HALLIBURTON ENERGY SERVICES, INC. (US) | 2015-12-17 | — | — | WO | claimed |
| WO-2015088471-A1 | ACIDIZING WITH SILANE TREATMENT TO CONTROL FINES MIGRATION IN A WELL | HALLIBURTON ENERGY SERVICES, INC. (US) | 2015-06-18 | — | — | WO | claimed |
| WO-2015041661-A1 | COMPOSITION FOR STABILIZING UNCONSOLIDATED FORMATION AND FINES AGGLOMERATION | HALLIBURTON ENERGY SERVICES, INC. (US) | 2015-03-26 | — | — | WO | claimed |
| WO-2014140291-A1 | A METHOD FOR PRODUCING A CRYSTALLINE FILM OF ZEOLITE AND/OR ZEOLITE LIKE CRYSTALS ON A POROUS SUBSTRATE | HEDLUND JONAS (SE) | 2014-09-18 | — | — | WO | claimed |
| WO-2014137195-A1 | METHOD FOR PRODUCING NANOFIBERS CAPABLE OF STORING AND TRANSFERRING NITRIC OXIDE AND NANOFIBERS CAPABLE OF STORING AND TRANSFERRING NITRIC OXIDE PRODUCED THEREBY | 광운대학교 산학협력단 (KR) | 2014-09-12 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260079095-A1 | SOLID SUPPORTS USEFUL FOR TISSUE ADHERENCE | SMCHD1, POF1B, MCTS1 | EPHX1 1242/4885DNM1 1492/4885TSHR 3662/4885 |
| US-12624143-B2 | Polyamide-functionalized silicon carbide (SiC) nanoparticles-based ceramic membrane for separating an oil and water mixture | SGMS2, SIK2, KAT2A | EPHX1 3957/4885DNM1 4707/4885TSHR 2657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.